Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity | |
Gu, Zili; Wang, Qingjie; Shi, Yanbin; Huang, Yi; Zhang, Jing; Zhang, Xinke; Lin, Guimei | |
刊名 | JOURNAL OF CONTROLLED RELEASE
![]() |
2018 | |
卷号 | 286页码:369-380 |
关键词 | Nanotechnology Liposome Docetaxel PD-L1 Immunochemotherapy |
DOI | 10.1016/j.jconrel.2018.08.011 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4573061 |
专题 | 山东大学 |
作者单位 | 1.Shandong Univ, Sch Pharmaceut Sci, 44 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China. 2.S |
推荐引用方式 GB/T 7714 | Gu, Zili,Wang, Qingjie,Shi, Yanbin,et al. Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity[J]. JOURNAL OF CONTROLLED RELEASE,2018,286:369-380. |
APA | Gu, Zili.,Wang, Qingjie.,Shi, Yanbin.,Huang, Yi.,Zhang, Jing.,...&Lin, Guimei.(2018).Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity.JOURNAL OF CONTROLLED RELEASE,286,369-380. |
MLA | Gu, Zili,et al."Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity".JOURNAL OF CONTROLLED RELEASE 286(2018):369-380. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论